Published in Biochem Biophys Res Commun on March 30, 1988
Exploring Buckwheat's Glucose Lowering Potential | NCT00841503
Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci U S A (1993) 3.53
chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci U S A (1993) 1.28
D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A (1993) 1.15
Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats. Proc Natl Acad Sci U S A (1994) 1.09
D-chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med (2010) 0.99
Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells. Proc Natl Acad Sci U S A (1990) 0.98
Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome. Appl Environ Microbiol (2006) 0.97
Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome. Metab Syndr Relat Disord (2010) 0.91
Diabetes and the role of inositol-containing lipids in insulin signaling. Mol Med (1999) 0.87
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol (2016) 0.87
Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor. Proc Natl Acad Sci U S A (1993) 0.86
Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients. Yonsei Med J (2005) 0.84
Novel Phosphoinositides in Barley Aleurone Cells (Additional Evidence for the Presence of Phosphatidyl-scyllo-Inositol). Plant Physiol (1997) 0.84
Transport in isolated rat hepatocytes of the phospho-oligosaccharide that mimics insulin action. Effects of adrenalectomy and glucocorticoid treatment. Biochem J (1991) 0.84
Isolation of insulin-sensitive phosphatidylinositol-glycan from rat adipocytes. Its impaired breakdown in the streptozotocin-diabetic rat. Biochem J (1990) 0.83
Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols. FASEB J (2012) 0.81
Insulin stimulation of pyruvate dehydrogenase in adipocytes involves two distinct signalling pathways. Biochem J (2003) 0.80
Insulin-induced phospho-oligosaccharide stimulates amino acid transport in isolated rat hepatocytes. Biochem J (1990) 0.80
The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry). Angew Chem Int Ed Engl (2015) 0.80
d- chiro-Inositol is absorbed but not synthesised in rodents. Br J Nutr (2009) 0.78
How to Achieve High-Quality Oocytes? The Key Role of Myo-Inositol and Melatonin. Int J Endocrinol (2016) 0.77
Phytochemical and Pharmacological Profiles of Three Fagopyrum Buckwheats. Int J Mol Sci (2016) 0.77
Growth hormone inhibits activation of phosphatidylinositol phospholipase C in adipose plasma membranes: evidence for a growth hormone-induced change in G protein function. Proc Natl Acad Sci U S A (1991) 0.77
Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols. Int J Endocrinol (2016) 0.76
Inositol, glycogen, insulin, and six nobelists. J Biol Chem (2013) 0.76
Inositol phospho-oligosaccharides from rat fibroblasts and adipocytes stimulate 3-O-methylglucose transport. Biochem J (1993) 0.75
Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols. Front Pharmacol (2017) 0.75
Effects of acute pinitol supplementation on plasma pinitol concentration, whole body glucose tolerance, and activation of the skeletal muscle insulin receptor in older humans. Horm Metab Res (2009) 0.75
The biological activity of structurally defined inositol glycans. Future Med Chem (2009) 0.75
A phosphatidylinositol-linkage-deficient T-cell mutant contains insulin-sensitive glycosyl-phosphatidylinositol. Biochem J (1992) 0.75
Perspectives in platelet-activating factor research. Pharmacol Rev (1987) 5.27
A core nursing library for practitioners. Am J Nurs (1970) 2.16
Function of the c-Myc oncogenic transcription factor. Exp Cell Res (1999) 2.11
Preparation of sepharose-bound poly (rI:rC). Biochem Biophys Res Commun (1971) 1.87
Molecular standardization of mating type terminology in the Gibberella fujikuroi species complex. Appl Environ Microbiol (1999) 1.84
Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem Biophys Res Commun (1985) 1.71
Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. Biochemistry (1983) 1.49
Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv (1997) 1.41
Minimum local analgesic concentration of ropivacaine for intra-operative caudal analgesia in pre-school and school age children. Anaesthesia (2010) 1.39
Idiopathic thrombocytopenic purpura during interferon-alpha 2B treatment for chronic hepatitis. Am J Gastroenterol (1994) 1.37
Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res (1977) 1.33
Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation. Mol Cell Biol (1998) 1.32
Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators. Science (1988) 1.30
Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin. Prostaglandins (1977) 1.30
HOXA5 regulates expression of the progesterone receptor. J Biol Chem (2000) 1.28
FSP95, a testis-specific 95-kilodalton fibrous sheath antigen that undergoes tyrosine phosphorylation in capacitated human spermatozoa. Biol Reprod (1999) 1.25
Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema. Eur J Pharmacol (1986) 1.24
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. Proc Natl Acad Sci U S A (1985) 1.24
My-1, the human myeloid-specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in lacto-N-fucopentaose III. Blood (1983) 1.23
S-nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol Lung Cell Mol Physiol (2000) 1.22
Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer Metastasis Rev (1995) 1.19
Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study. Pharmacopsychiatry (2006) 1.16
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues. J Biol Chem (1992) 1.15
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor. J Biol Chem (1985) 1.14
Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Lab Invest (1985) 1.14
Identification of the biologically active form of sulindac. J Pharmacol Exp Ther (1977) 1.14
Holliday intermediates and reaction by-products in FLP protein-promoted site-specific recombination. Mol Cell Biol (1988) 1.13
Many monoclonal antibodies with an apparent specificity for certain lung cancers are directed against a sugar sequence found in lacto-N-fucopentaose III. Arch Biochem Biophys (1983) 1.09
Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats. Proc Natl Acad Sci U S A (1994) 1.09
Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk. J Biol Chem (1992) 1.09
Nucleosides. 3. Studies on 5-methylamino-2'-deoxyuridine as a specific antiherpes agent. J Med Chem (1966) 1.08
Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys. Endocrinology (1993) 1.07
Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar. Sex Transm Infect (2005) 1.07
Effect of surface modification on aggregation of phospholipid vesicles. Proc Natl Acad Sci U S A (1981) 1.04
Rabbit skeletal muscle protein kinase. Conversion from cAMP dependent to independent form by chemical perturbations. Biochemistry (1975) 1.04
Specific binding sites for platelet activating factor in human lung tissues. Biochem Biophys Res Commun (1985) 1.01
Kinetic studies on the dissociation of adenosine cyclic 3',5'-monophosphate from the regulatory subunit of protein kinase from rabbit skeletal muscle. Biochemistry (1980) 1.01
Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2200 cases). Int J Surg Investig (2001) 1.00
Progress in a replicated selection for elevated blood ethanol concentrations in HDID mice. Genes Brain Behav (2013) 0.99
Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells. Proc Natl Acad Sci U S A (1990) 0.98
Synthesis and analgesic activity of 1,3-dihydro-3-(substituted phenyl)imidazo[4,5-b]pyridin-2-ones and 3-(substituted phenyl)-1,2,3-triazolo[4,5-b]pyridines. J Med Chem (1978) 0.95
Biochemical and ultrastructural study of Leu M1 antigen in Reed-Sternberg cells: comparison with granulocytes and interdigitating reticulum cells. J Natl Cancer Inst (1986) 0.95
Knowledge of sex partner treatment for past bacterial STI and risk of current STI. Sex Transm Infect (2005) 0.94
Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase. J Biol Chem (1982) 0.94
Co-localization of the inositol 1,4,5-trisphosphate receptor and calreticulin in the equatorial segment and in membrane bounded vesicles in the cytoplasmic droplet of human spermatozoa. Mol Hum Reprod (2001) 0.94
Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycaemia. Diabetologia (1996) 0.93
Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: impact on the left ventricle. J Thorac Cardiovasc Surg (2006) 0.93
Modified in vivo behavior of liposomes containing synthetic glycolipids. Biochim Biophys Acta (1981) 0.91
Structure-activity relationships of aminoalkyl and -aryl glycosides having insulin-like activity. J Med Chem (1978) 0.91
Insulin control of glycogen synthesis. Adv Cyclic Nucleotide Res (1978) 0.91
Insulin-like, and insulin-antagonistic, carbohydrate derivatives. The synthesis of aryl and aralkyl D-mannopyranosides and 1-thio-D-mannopyranosides. Carbohydr Res (1980) 0.91
Understanding bamboo flowering based on large-scale analysis of expressed sequence tags. Genet Mol Res (2010) 0.90
Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. Biochem Biophys Res Commun (1984) 0.90
Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy. J Basic Clin Physiol Pharmacol (1998) 0.90
Evidence for an essential arginine recognition site on adenosine 3':5'-cyclic monophosphate-dependent protein kinase of rabbit skeletal muscle. Biochem J (1978) 0.89
Insulin mediators: structure and formation. Cold Spring Harb Symp Quant Biol (1988) 0.89
A model for the prostaglandin synthetase cyclooxygenation site and its inhibition by antiinflammatory arylacetic acids. J Med Chem (1977) 0.89
Insulin mediators are the signal transduction system responsible for insulin's actions on human placental steroidogenesis. Endocrinology (1991) 0.88
Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline. Pharmacopsychiatry (2005) 0.88
Development of muscarinic analgesics derived from epibatidine: role of the M4 receptor subtype. J Pharmacol Exp Ther (1999) 0.87
Insulin mediators and the control of pyruvate dehydrogenase complex. Ann N Y Acad Sci (1989) 0.87
Nucleosides. II. Reactions of 5'-trityluridine 2',3'-O-thionocarbonate. J Org Chem (1965) 0.87
Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor. Proc Natl Acad Sci U S A (1993) 0.86
Perspectives in nonsteroidal anti-inflammatory agents. Angew Chem Int Ed Engl (1972) 0.85
Membrane effects of antiinflammatory agents. 1. Interaction of sulindac and its metabolites with phospholipid membrane, a magnetic resonance study. J Med Chem (1981) 0.84
Epibatidine is a nicotinic analgesic. Eur J Pharmacol (1993) 0.84
Membrane effects of antiinflammatory agents. 2. Interaction of nonsteroidal antiinflammatory drugs with liposome and purple membranes. J Med Chem (1981) 0.84
Human papillomavirus-16 E6/E7 transfected retinal cell line expresses the Müller cell phenotype. Exp Eye Res (1997) 0.84
Effects of the position of internal histidine residues on the collision-induced fragmentation of triply protonated tryptic peptides. J Am Soc Mass Spectrom (2001) 0.84
Burger Award address. Toward more selective antiarthritic therapy. J Med Chem (1981) 0.83
The use of midazolam and small-dose ketamine for sedation and analgesia during local anesthesia. Anesth Analg (2001) 0.83
Parallel changes of blood flow and heterogeneity of capillary plasma perfusion in rat brains during hypocapnia. Am J Physiol (1996) 0.83
A putative mediator of insulin action which inhibits adenylate cyclase and adenosine 3',5'-monophosphate-dependent protein kinase: partial purification from rat liver: site and kinetic mechanism of action. Endocrinology (1987) 0.83
Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. J Neurochem (2002) 0.83
Effects of insulin treatment on the activities of phosphoprotein phosphatase and its inhibitors. Acta Endocrinol (Copenh) (1980) 0.83
Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 0.82
Anterior tibial artery flap: anatomy and case report. Br J Plast Surg (1987) 0.81
Targeting of synthetically glycosylated human placental glucocerebrosidase. Biochem Med (1985) 0.81
Discovery of diflunisal. Br J Clin Pharmacol (1977) 0.81
Monoclonal antibody to human eosinophils recognizing 95 kD surface membrane antigen. Hybridoma (1983) 0.81
Methylation of γ-carboxylated Glu (Gla) allows detection by liquid chromatography-mass spectrometry and the identification of Gla residues in the γ-glutamyl carboxylase. J Proteome Res (2013) 0.81
Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent. J Pharmacol Exp Ther (1994) 0.81
Selective inhibition of the insulin-stimulated phosphorylation of the 95,000 dalton subunit of the insulin receptor by TAME or BAEE. Biochem Biophys Res Commun (1984) 0.81
Synthesis and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids. J Med Chem (1978) 0.81
Video-assisted thoracoscopic T2 sympathetic block by clipping for palmar hyperhidrosis: analysis of 52 cases. J Laparoendosc Adv Surg Tech A (2001) 0.80
Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian-Indians. Am J Cardiol (2001) 0.80
Determination of cobalt in urine by gas chromatography-mass spectrometry employing nickel as an internal standard. J Chromatogr (1992) 0.80
Aza analogs of 5-(p-fluorophenyl)salicylic acid. J Med Chem (1971) 0.80
Determination of lead in urine and whole blood by stable isotope dilution gas chromatography-mass spectrometry. Clin Chem (1994) 0.80
Properties of glycogen synthase and phosphorylase from Biomphalaria glabrata (mollusca). J Parasitol (1982) 0.79
Nucleosides and nucleotides as potential therapeutic agents. Angew Chem Int Ed Engl (1970) 0.79
Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophages. Proc Natl Acad Sci U S A (1981) 0.79
Hormonal control of glycogen metabolism. Adv Exp Med Biol (1979) 0.78